Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Jack Adamo
Insiders Plus
Ian Wyatt
Top Stock Insights

4 Graham-Buffett style stocks


Bookmark and Share
by J. Royden Ward, editor Cabot Benjamin Graham Value Letter

J. Royden WardBenjamin Graham has been recognized for decades as the father of value investing. Warren Buffett was a student of Graham at Columbia University and later worked for Mr. Graham for several years.

For our latest special report, I combine Warren Buffett’s and Ben Graham’s criteria for choosing stocks; here, we look at four high-quality companies that fit our criteria.

To find these Graham-Buffett style investment opportunities, I looked for stocks with:
  1. Free cash flow more than $20 million.
  2. Net profit margin more than 15%.
  3. Return on equity more than 15%.
  4. Discounted cash flow value higher than current price.
  5. Market capitalization more than $1 billion.
  6. Standard & Poor’s rating of B+ or better.
  7. Positive earnings growth during the past five years with no deficits.
  8. Dividends currently paid.
These stocks sell at sensible prices, offer reasonable appreciation potential and provide solid dividends. I am confident these high-quality stocks will fare very well during the next six months.

Aflac (AFL) is the world’s largest supplemental cancer insurance provider, deriving 75% of its business from Japan. It provides insurance to one out of every four Japanese households.

Aflac has expanded its product line and added new marketing venues in recent years. Non-cancer insurance policies now account for 70 percent of new sales.

Sales increased 13% and earnings per share rose 9% during the 12 months ended 6/30/12. I forecast sales and earnings per share growth of 9% during the next 12 months.

Growth could receive an additional boost if U.S. sales improve noticeably. AFL shares sell at 7.5 times latest EPS, which is well below the 10-year average P/E of 10.6. The 2.7% dividend yield adds significant value.

Established in 1850, American Express (AXP) is a leading global payments and travel services company.

Sales and earnings declined in 2008 and 2009, but rebounded to record levels in 2011. The company’s strong balance sheet and low customer defaults helped it weather the recent recession.

I forecast sales growth of 7% and EPS growth of 12% during the next 12 months, similar to the preceding 12 months ended 6/30/12.

The company’s new technologies in digital and mobile payments will help produce solid growth during the next several years.

AXP shares are undervalued at 13.4 times latest EPS.  The shares are low risk and offer a dividend yield of 1.4%. Warren Buffett’s Berkshire Hathaway owns 13% of AXP.

More than 90% of the mobile offshore drilling rigs manufactured in the past 20 years use drilling components manufactured by National Oilwell Varco (NOV).

Oil and natural gas companies are focusing on oil drilling and placing less emphasis on natural gas drilling because of the low prices and profits of natural gas. The switchover is creating new demand for National’s products and services.

In August, the company agreed to purchase Robbins & Myers for $2.5 billion. Robbins makes pumps and valves for the oil drilling industry, and the company’s rapid sales and earnings growth will enhance National’s results in future years.

National’s sales and earnings jumped 32% during the past 12 months ended 6/30/12. Sales and EPS will likely increase 15% during the next 12-month period.

NOV sells at a reasonable 15.4 times my forecast EPS of 6.25. The stock pays a dividend yielding 0.6% and is low risk.

Nu Skin Enterprises (NUS) develops and distributes personal care products and nutritional supplements. Based in Provo, Utah, Nu Skin derives a whopping 86% of sales from outside North and South America. Europe contributes less than 10% of sales.

Weak sales in Japan and Europe are being offset by quite strong sales throughout Nu Skin’s other markets. New products are selling well, and additional products will be introduced during the next several months.

Nu Skin’s sales increased 23% and EPS soared 56% during the past 12 months ended 6/30/12. I expect sales to increase 12% and EPS to rise 14% during the next 12 months.

At 13.8 times latest EPS, NUS shares are attractive. The dividend yield of 1.9% and low risk rating create an excellent investment opportunity.

Learn more about this financial newsletter at J. Royden Ward's Cabot Benjamin Graham Value Letter.

Related articles:

Advertisement
Banner
News Flash

Air and auto parts: Rebound buys
by Richard Moroney, editor Upside Stocks

Here, we profile two are attractive rebound plays -- Penske Automotive (PAG) and Triumph (TGI). Both seem capable of attracting investors’ attention and rallying in the year ahead.


Read more...

 

Fidelity: International buys
by Jim Lowell, editor Fidelity Investor

I continue to think the best way to pursue foreign stock opportunities is through managers with longstanding expertise in the foreign stock arena. Here's a look at four of our buy-rated international funds.


Read more...


   

Parexel: One-stop shop in clinical trials
by Mike Cintolo, editor Cabot Top Ten Trader

Parexel International (PRXL) has a great niche in the pharmaceutical industry. Its main service is outsourcing medical research and clinical trials of candidate drugs. Its one-stop-shopping approach to drug development and trials lets Parexel take over the work of an entire division, saving clients enormous amounts of expense.


Read more...

 

Cisco: 'Plenty of room for growth'
by Brian Hicks, editor The Wealth Advisory

CEO John Chambers is making us look good; it is now nine consecutive quarters that Cisco Systems (CSCO) has beaten analysts' earnings estimates.


Read more...

 

Strong growth at value prices
by Stephen Quickel, editor US Investment Report

In selecting new stocks for the Recommended List we aim for leaders in top growth sectors that we think can generate price gains of at least 20%. Here's a look at 5 'buys'.


Read more...

 

Military matters: Top picks in defense
by Jim Powell, editor Global Changes & Opportunities

I continue to recommend leading U.S. defense stocks that have been greatly oversold by investors who are worried about deep cutbacks. Although some expensive “big iron” contracts will be cancelled, I believe many new high tech orders will more than make up for their loss.


Read more...

 

StoneMor: Timely buy in untimely market
by Steve Mauzy, contributing editor Daily Profit

Thanks to baby boomers hitting their golden years en masse, annual deaths in the United States are expected to rise to 3.2 million in 2030 from 2.6 million in 2010. For income-and-yield investors, there's really only one choice in the cemetery sector -- StoneMor Partners (STON), which yields over 9%.


Read more...

 

Norfolk Southern: Rail for reinvesting
by Vita Nelson, editor Direct Investing

Choosing to own companies that grow their earnings and dividends consistently over time means taking advantage of compounding both within the company and within the stock market, no matter what the latest noise may be.


Read more...

 

MOO: A farming favorite
by Doug Fabian, editor Making Money Alert

Developing nations and increasing populations are raising global demand for food production. Farming, and all its component stages, should benefit. The appropriately named Market Vectors Agribusiness (MOO) should profit from this need for heightened farm production.


Read more...

 

Seasonal sector selections
by Jim Stack, editor InvesTech Market Analyst

The bear market warning flags that would warrant a more defensive stance are not evident at this time. However, as we enter the seasonally soft summer time frame, we should review sector allocation to ensure that portfolios are positioned to weather any downturn.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary